This is from remarks by U.S. Trade Representative Katherine Tai yesterday at a WTO virtual conference on COVID-19 vaccine equity:
We hope to hear more today about how the market once again has failed in meeting the health needs of developing countries. As part of that we have to consider what modifications and reforms to our trade rules might be necessary to reflect what we have learned.
I don't feel like I've been following vaccine production and distribution issues as closely as some other people have, but nevertheless my sense is that many of the problems result from patents and other IP issues (which are government intervention rather than the free market) and from the way developed country governments structured their purchases of the vaccines (which, again, is the government not the market). And, of course, there were a wide range of new export restrictions imposed by governments, and plenty of existing tariffs, that got in the way of trade in all of the various products needed by developing countries.
I don't know what exactly would have happened if we had a free market in all of the various health products at issue here, and no doubt there would have been some problems. But I think that developed country governments need to consider how their actions have directly led to the failures in meeting the health needs of developing countries. There is still time to change course and I hope the Biden administration is serious about this.
